SAN FRANCISCO, CA – July 16, 2019 – Notable, which is redefining cancer treatment with a clinically validated platform that rapidly advances cancer drug development at a fraction of the traditional time and cost, announced a $40M Series B round. The round is co-led by B Capital Group and LifeForce Capital. LifeForce is a returning […]